To:
(Enter e-mail address of recipient)
From:
(Enter your e-mail address)
Subject:
Comments:
(Customise the e-mail with your own comments)
  Novogen’s Phenoxodiol proves well tolerated with demonstrated activity in cancer patients
Data has been presented at a US medical conference from the first human clinical study of Novogen Limited’s novel anti-c...